Compare CVS Health Corp (CVS) vs Zillow Group Inc Class A (ZG) Price & Performance

CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.

The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.

Zillow Group (ZG) trades at $34.07, up 0.35% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with 2025 revenue of $2.58B and a return to profitability ($23M net income) after years of losses. However, valuation remains elevated with a P/E of 149, while multiple class action lawsuits create near-term uncertainty. The stock faces resistance at $35 with support at $33.

ZG presents a mixed investment case with strong revenue growth and business model transition offset by legal overhangs and high valuation. The preferred agent model drives monetization improvement, but the stock requires careful risk management given the legal proceedings and technical bearish signals. Upside exists to the $47.56 consensus target if execution continues.